Aurobindo Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.
Aurobindo Pharma Ltd., with Security Code 524804, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 75,801.50 | 9,073.50 | 77,157.70 | 15.51 | -18,058.60 | 1,356.20 | -3,543.30 | 12,425.60 |
2023-10-01 | 2023-12-31 | 26,920.30 | 6,237.80 | 30,231.60 | 10.65 | -4,010.00 | 3,311.30 | -643.50 | 6,872.20 |
2023-10-01 | 2023-12-31 | 73,517.80 | 9,399.70 | 75,143.00 | 16.04 | -16,102.20 | 1,625.20 | -4,232.70 | 12,650.10 |
2023-07-01 | 2023-09-30 | 26,687.60 | 4,157.40 | 27,358.40 | 6.48 | -3,690.90 | 670.80 | -657.90 | 5,097.80 |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | -3% |
3 Years: | -12% |
TTM: | -17% |
Compounded Profit Growth | |
---|---|
10 Years: | 5% |
5 Years: | 4% |
3 Years: | -15% |
TTM: | 56% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 15% |
3 Years: | 7% |
1 Year: | 70% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 8% |
3 Years: | 5% |
TTM: | 17% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 6% |
3 Years: | -1% |
TTM: | 71% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 15% |
3 Years: | 7% |
1 Year: | 70% |